This $4,343,333 federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports Drexel University's research on mild traumatic brain injury-related vision disorders. The award, with a performance period from September 2024 to September 2028, will fund the development of a patient-reported outcome measure (PROM), validation of clinical outcome measures, natural history studies, and interventions for these vision disorders. Drexel University, a private research university in Philadelphia, will leverage its academic expertise across disciplines such as engineering, biomedical sciences, and public health to conduct this comprehensive research initiative addressing an important medical challenge for military service members and the broader population.
Generated 3/18/25, 5:01 AM